3°C + ++ + 035-4 4 Belnacasan 2-3 Formed         035-6

** 9 2-3 Formed         036-1 7 6 Loose Normal ++ + + 036-2 8 3 Loose         036-3 9 2 Loose         * +: 6–10/ high power field (HPF) ++: >10/HPF. **: Fecal samples collected at patient discharge from hospital. Group C2 included eight children with diarrhea, who were further divided into three subgroups, based on the most dominant fecal bacterial species at admission. Group C2a included two children who had S. salivarius as the most dominant fecal bacterial species. Group C2b included three children who had Streptococcus sp. as the most dominant species. Group C2c included three children who had S. bovis group as the most dominant species (Figure 2A and B). For Patient 011 (age 2.5 years) in Group C2a, the percentage of S. salivarius in the fecal microflora was reduced from 78.95% at admission to 31.43% during check details recovery (Figure 2B), based on 442 sequences analyzed. Patient 021 (age 8 months) had the percentage of S. salivarius in the fecal microflora of 58.56% at admission, which increased to 60.0% during recovery and then to 76.67% after recovery (Figure 2B). Group C2b had Streptococcus sp. as the dominant fecal species at admission. For Patient selleck screening library 016 (age 9 months), the percentage of Streptococcus sp. in fecal microflora was reduced from 51.28% to 15.65% during recovery (3 days of treatment), and then to 4.67% after recovery

(12 days of treatment) (Figure 2B), based on 456 16S rRNA gene sequences analyzed. For Patient 019 (age 4 months), the percentage of Streptococcus sp. in fecal microflora was reduced from 40.54% at admission to 7.08% during recovery (6 days Cyclic nucleotide phosphodiesterase of treatment) and then to 1.77% after recovery (11 days of treatment) (Figure 2A and B), based on 448 16S rRNA gene sequences analyzed. For Patient 023 (age 5 months), the percentage of Streptococcus sp. in fecal microflora was reduced from 26.05% at admission to 13.56% during recovery (5 days of treatment) and then to zero after recovery (9 days of treatment) (Figure 2B), based on 440 16S rRNA gene sequences

analyzed. All three patients in Group C2c had S. bovis group as their most dominant fecal bacterial species at admission. For Patient 033 (age 2 months), the percentage of S. bovis group in fecal microflora was reduced from 26.84% at admission to zero during recovery (3 days of treatment) (Figure 2B). It was not detected in feces sampled at discharge from the hospital, after 5 days of treatment. For Patient 017 (age 1.5 years), the percentage of S. bovis group in fecal microflora was reduced from 39.82% at admission to zero during recovery (3 days of treatment) (Figure 2B). It was not detected in feces sampled at discharge from hospital, after 5 days of treatment. For Patient 035 (age 8 months), the percentage of S. bovis group in fecal microflora was reduced from 42.